Metastatic androgen pathway modulation-naïve or -sensitive prostate cancer was previously referred to as metastatic hormone-sensitive prostate cancer.

Results showed ozekibart significantly reduced the risk of disease progression or death by 52% compared with placebo. The Food and Drug Administration (FDA) has accepted for review the Biologics ...

Credit: Bayer. Two phase 3 trials supported the approval of gadoquatrane, a novel macrocyclic GBCA for imaging CNS and non-CNS pathologies. The novel macrocyclic contrast agent delivers high-quality ...

A voluntary recall has been issued for a lot of Beekeeper’s Naturals Saline Nasal Spray following the detection of Aspergillus mold.

Findings showed navacaprant did not significantly improve MADRS total scores compared with placebo in either KOASTAL-2 (P =.813) or KOASTAL-3 (P =.480). Topline data were announced from two phase 3 ...

Mesothelioma deaths and diagnoses continue to rise in the United States despite regulation limiting the use of asbestos, according to a study published online June 11 in JCO Global Oncology. Kyle ...

Three studies show benefits in adults inadequately controlled with diet and exercise, receiving metformin, using basal insulin ...

The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.

A wearable ultrasound patch can provide continuous, real-time information about blood flow in the fetus and umbilical cord, according to a study published online May 26 in Nature Biotechnology. Geonho ...

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.

The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

A new extended maintenance regimen for Ebglyss has been approved for eligible patients with moderate to severe atopic dermatitis.